Skip to main
OFIX

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical is showing signs of growth, especially within their Global Spine segment, as well as strong cash flow and a solid balance sheet. However, the current distributor transition and potential legal settlement may have impacted short-term performance. With new product launches and a promising pipeline, the company has potential for long-term success but may face some near-term challenges.

Bears say

Orthofix Medical is currently experiencing difficulties with their adjusted EBITDA margin and weaker demand for their Global Limb Reconstruction segment. The recent pushback of their longer-term adjusted EBITDA margin target from 2027 to 2028 also indicates potential challenges ahead. This, paired with lower guidance for FY/26 and disappointing results in comparison to our estimates warrants a negative outlook on the stock.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.